Isfahan University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Comparing Efficacy and Safety of P013, a Proposed Pertuzumab Biosimilar, With the Reference Product in Her2-Positive Breast Cancer Patients: A Randomized, Phase Iii, Equivalency Clinical Trial
Mahnaz Roayaei
Mahnaz Roayaei

Associate Professor of Radiotherapy

Department of Radiooncology, School of Medicine

Cancer Prevention Research Center

Seyyed Al-Shohada Hospital

Isfahan University of Medical Sciences

All Documents
19. Effects of Probiotics With or Without Honey on Radiation-Induced Diarrhea, International Journal of Radiation Research (2016)
35. Locoregional Recurrence of Breast Cancer and Its Predictive Factors, Journal of Isfahan Medical School (2012)